Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder: a pooled analysis of phase III clinical trials

被引：0
|
作者：
Khan, A. [1 ]
Song, W. [2 ]
Edwards, J. [2 ]
Ruth, A. [3 ]
机构：
[1] Northwest Clin Res Ctr, Belleview, FL USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Prescott Med Commun Grp, Chicago, IL USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70379-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S253 / S254
页数：2
相关论文
共 50 条
  • [21] Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials
    Kohler-Forsherg, O.
    Lydholm, C. N.
    Hjorthoj, C.
    Nordentoft, M.
    Mors, O.
    Benros, M. E.
    ACTA PSYCHIATRICA SCANDINAVICA, 2019, 139 (05) : 404 - 419
  • [22] Efficacy of lumateperone in pooled short-term late-phase clinical trials for the treatment of major depressive episodes associated with bipolar II disorder
    Durgam, Suresh
    Lakkis, Hassan
    Kozauer, Susan G.
    Chen, Changzheng
    D'Souza, Ian
    McIntyre, Roger S.
    BIPOLAR DISORDERS, 2023, 25 : 99 - 99
  • [23] Efficacy of Lumateperone in Pooled Short-Term Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar II Disorder
    Durgam, Suresh
    Lakkis, Hassan
    Kozauer, Susan G.
    Chen, Richard
    D'Souza, Ian
    McIntyre, Roger S.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 192 - 193
  • [24] Pooled analysis: 2 randomised clinical trials confirms superiority of escitalopram over paroxetine in treatment of major depressive disorder
    Kasper, S.
    Baldwin, D.
    Boulenger, J. P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S297 - S298
  • [25] Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials
    Lam, Raymond W.
    Andersen, Henning F.
    Wade, Alan G.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 181 - 187
  • [26] Efficacy of Lumateperone in Pooled Short-Term LatePhase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar II Disorder
    Durgam, Suresh
    Lakkis, Hassan
    Kozauer, Susan G.
    Chen, Richard
    D'Souza, Ian
    McIntyre, Roger S.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 192 - 193
  • [27] Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
    Khan, Arif
    Sambunaris, Angelo
    Edwards, John
    Ruth, Adam
    Robinson, Donald S.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (02) : 86 - 92
  • [28] Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials
    Gorman, Jack M.
    Korotzer, Andrew
    Su, Guojin
    CNS SPECTRUMS, 2002, 7 (04) : 40 - 44
  • [29] VILAZODONE: A NEW TREATMENT OPTION FOR MAJOR DEPRESSIVE DISORDER
    Owen, R. T.
    DRUGS OF TODAY, 2011, 47 (07) : 531 - 537
  • [30] Evidence for the use of vilazodone in the treatment of major depressive disorder
    Reinhold, Jennifer A.
    Mandos, Laura A.
    Lohoff, Falk W.
    Rickels, Karl
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2215 - 2224
12345